Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - VANGUARD HEALTH SYSTEMS INC | c23895exv99w1.htm |
| EX-99.3 - EXHIBIT 99.3 - VANGUARD HEALTH SYSTEMS INC | c23895exv99w3.htm |
| 8-K - FORM 8-K - VANGUARD HEALTH SYSTEMS INC | c23895e8vk.htm |
EXHIBIT 99.2
Vanguard Health Systems, Inc.
Supplementary Financial Information
Supplementary Financial Information
Adjusted EBITDA Margin
Presentation of Most Directly Comparable GAAP Financial Measure (Net
Income/Loss Attributable to Vanguard Health Systems, Inc. Stockholders Margin)
and Reconciliation of Adjusted EBITDA to Net Income/Loss Attributable to Vanguard Health Systems, Inc.
Stockholders Margin
| Quarter ended September 30, | ||||||||
| (in millions, unaudited) | 2010 | 2011 | ||||||
Adjusted EBITDA |
$ | 77.7 | $ | 122.8 | ||||
Total revenues |
862.1 | 1,443.5 | ||||||
Adjusted EBITDA Margin |
9.0 | % | 8.5 | % | ||||
Adjusted EBITDA |
$ | 77.7 | $ | 122.8 | ||||
Interest, net |
(34.8 | ) | (45.8 | ) | ||||
Income tax benefit |
2.4 | 13.6 | ||||||
Depreciation and amortization |
(37.2 | ) | (62.6 | ) | ||||
Non-controlling interests |
(1.0 | ) | 2.3 | |||||
Gain on disposal of assets |
— | 1.2 | ||||||
Equity method income |
0.3 | 0.1 | ||||||
Stock compensation |
(1.2 | ) | (0.7 | ) | ||||
Monitoring fees and expenses |
(1.4 | ) | — | |||||
Acquisition related expenses |
(3.7 | ) | (12.2 | ) | ||||
Debt extinguishment costs |
— | (38.9 | ) | |||||
Impairment and restructuring charges |
— | 0.1 | ||||||
Pension credits |
— | 1.0 | ||||||
Income (loss) from discontinued
operations, net of taxes |
0.1 | (0.1 | ) | |||||
Net income (loss) attributable to Vanguard
Health Systems, Inc. stockholders |
$ | 1.2 | $ | (19.2 | ) | |||
Total revenues |
$ | 862.1 | $ | 1,443.5 | ||||
Net income (loss) attributable to Vanguard
Health Systems, Inc. stockholders margin |
0.1 | % | (1.3 | )% | ||||